Inactive/Delisted stock
Biohaven Stock (NYSE:BHVN)
Previous Close
$14.76
52W Range
$13.87 - $55.70
50D Avg
$17.27
200D Avg
$33.82
Market Cap
$1.49B
Avg Vol (3M)
$2.24M
Beta
3.64
Div Yield
-
BHVN Company Profile
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.